Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-20

Clinical Trial Update: Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent

View source ↗

Summary

Pfizer sponsored a non-interventional study in Indian patients with advanced renal cell carcinoma treated with Sutent (sunitinib). The study has completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sutent (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Renal Cell Carcinoma | Status: COMPLETED | Results posted: 2013-12-20